APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glass Vial for Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Glass Vial for Vaccine Market Outlook and Growth Opportunities 2026

30 December 2025190 pages

Choose your research edition.

Industry ResearchGlass Vial for Vaccine Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Glass Vial for Vaccine Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Glass Vial for Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glass Vial for Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Glass Vial for Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Glass Vial for Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Glass Vial for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glass Vial for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glass Vial for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Glass Vial for Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Glass Vial for Vaccine market include Schott AG, DWK Life Sciences, Richland Glass, Nipro, Pacific Vial Manufacturing, Origin Ltd, Stevanato Group, SGD Pharma and Piramal Glass, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Glass Vial for Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glass Vial for Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glass Vial for Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glass Vial for Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Glass Vial for Vaccine Segment by Company

Schott AG

DWK Life Sciences

Richland Glass

Nipro

Pacific Vial Manufacturing

Origin Ltd

Stevanato Group

SGD Pharma

Piramal Glass

Zheng Chuan

Shandong Pharmaceutical Glass

Zheng Li

Gerresheimer

Four Stars Glass

JOTOP Glass

Glass Vial for Vaccine Segment by Type

Molded Glass Vial

Tubular Glass Vial

Glass Vial for Vaccine Segment by Application

Preventive Vaccine

Therapeutic Vaccine

Glass Vial for Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Glass Vial for Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Glass Vial for Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Glass Vial for Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Glass Vial for Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glass Vial for Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glass Vial for Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glass Vial for Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glass Vial for Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glass Vial for Vaccine industry.

Chapter 3: Detailed analysis of Glass Vial for Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Glass Vial for Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Glass Vial for Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Glass Vial for Vaccine Industry Trends Table 2. Glass Vial for Vaccine Industry Drivers Table 3. Glass Vial for Vaccine Industry Opportunities and Challenges Table 4. Glass Vial for Vaccine Industry Restraints Table 5. Global Glass Vial for Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Glass Vial for Vaccine Revenue Share by Company (2021-2026) Table 7. Global Glass Vial for Vaccine Sales Volume by Company (k units) & (2021-2026) Table 8. Global Glass Vial for Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Glass Vial for Vaccine Average Price (USD/unit) of Company (2021-2026) Table 10. Global Glass Vial for Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Glass Vial for Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Glass Vial for Vaccine Company, Product Type & Application Table 13. Global Glass Vial for Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Glass Vial for Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Molded Glass Vial Table 18. Significant Companies of Tubular Glass Vial Table 19. Global Glass Vial for Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Glass Vial for Vaccine Sales Volume by Type (2021-2026) & (k units) Table 21. Global Glass Vial for Vaccine Sales Volume by Type (2027-2032) & (k units) Table 22. Global Glass Vial for Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Glass Vial for Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Glass Vial for Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Glass Vial for Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Glass Vial for Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Glass Vial for Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Glass Vial for Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Preventive Vaccine Table 30. Significant Companies of Therapeutic Vaccine Table 31. Global Glass Vial for Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Glass Vial for Vaccine Sales Volume by Application (2021-2026) & (k units) Table 33. Global Glass Vial for Vaccine Sales Volume by Application (2027-2032) & (k units) Table 34. Global Glass Vial for Vaccine Sales Volume Share by Application (2021-2026) Table 35. Global Glass Vial for Vaccine Sales Volume Share by Application (2027-2032) Table 36. Global Glass Vial for Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Glass Vial for Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Glass Vial for Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Glass Vial for Vaccine Sales Value Share by Application (2021-2026) Table 40. Global Glass Vial for Vaccine Sales Value Share by Application (2027-2032) Table 41. Global Glass Vial for Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Glass Vial for Vaccine Sales by Region (2021-2026) & (k units) Table 43. Global Glass Vial for Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Glass Vial for Vaccine Sales by Region (2027-2032) & (k units) Table 45. Global Glass Vial for Vaccine Sales Market Share by Region (2027-2032) Table 46. Global Glass Vial for Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Glass Vial for Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Glass Vial for Vaccine Sales Value Share by Region (2021-2026) Table 49. Global Glass Vial for Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Glass Vial for Vaccine Sales Value Share by Region (2027-2032) Table 51. Global Glass Vial for Vaccine Market Average Price (USD/unit) by Region (2021-2026) Table 52. Global Glass Vial for Vaccine Market Average Price (USD/unit) by Region (2027-2032) Table 53. Global Glass Vial for Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Glass Vial for Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Glass Vial for Vaccine Sales by Country (2021-2026) & (k units) Table 56. Global Glass Vial for Vaccine Sales Market Share by Country (2021-2026) Table 57. Global Glass Vial for Vaccine Sales by Country (2027-2032) & (k units) Table 58. Global Glass Vial for Vaccine Sales Market Share by Country (2027-2032) Table 59. Global Glass Vial for Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Glass Vial for Vaccine Sales Value Market Share by Country (2021-2026) Table 61. Global Glass Vial for Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Glass Vial for Vaccine Sales Value Market Share by Country (2027-2032) Table 63. Schott AG Company Information Table 64. Schott AG Business Overview Table 65. Schott AG Glass Vial for Vaccine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Schott AG Glass Vial for Vaccine Product Portfolio Table 67. Schott AG Recent Development Table 68. DWK Life Sciences Company Information Table 69. DWK Life Sciences Business Overview Table 70. DWK Life Sciences Glass Vial for Vaccine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. DWK Life Sciences Glass Vial for Vaccine Product Portfolio Table 72. DWK Life Sciences Recent Development Table 73. Richland Glass Company Information Table 74. Richland Glass Business Overview Table 75. Richland Glass Glass Vial for Vaccine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Richland Glass Glass Vial for Vaccine Product Portfolio Table 77. Richland Glass Recent Development Table 78. Nipro Company Information Table 79. Nipro Business Overview Table 80. Nipro Glass Vial for Vaccine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Nipro Glass Vial for Vaccine Product Portfolio Table 82. Nipro Recent Development Table 83. Pacific Vial Manufacturing Company Information Table 84. Pacific Vial Manufacturing Business Overview Table 85. Pacific Vial Manufacturing Glass Vial for Vaccine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Pacific Vial Manufacturing Glass Vial for Vaccine Product Portfolio Table 87. Pacific Vial Manufacturing Recent Development Table 88. Origin Ltd Company Information Table 89. Origin Ltd Business Overview Table 90. Origin Ltd Glass Vial for Vaccine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Origin Ltd Glass Vial for Vaccine Product Portfolio Table 92. Origin Ltd Recent Development Table 93. Stevanato Group Company Information Table 94. Stevanato Group Business Overview Table 95. Stevanato Group Glass Vial for Vaccine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Stevanato Group Glass Vial for Vaccine Product Portfolio Table 97. Stevanato Group Recent Development Table 98. SGD Pharma Company Information Table 99. SGD Pharma Business Overview Table 100. SGD Pharma Glass Vial for Vaccine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. SGD Pharma Glass Vial for Vaccine Product Portfolio Table 102. SGD Pharma Recent Development Table 103. Piramal Glass Company Information Table 104. Piramal Glass Business Overview Table 105. Piramal Glass Glass Vial for Vaccine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Piramal Glass Glass Vial for Vaccine Product Portfolio Table 107. Piramal Glass Recent Development Table 108. Zheng Chuan Company Information Table 109. Zheng Chuan Business Overview Table 110. Zheng Chuan Glass Vial for Vaccine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Zheng Chuan Glass Vial for Vaccine Product Portfolio Table 112. Zheng Chuan Recent Development Table 113. Shandong Pharmaceutical Glass Company Information Table 114. Shandong Pharmaceutical Glass Business Overview Table 115. Shandong Pharmaceutical Glass Glass Vial for Vaccine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Shandong Pharmaceutical Glass Glass Vial for Vaccine Product Portfolio Table 117. Shandong Pharmaceutical Glass Recent Development Table 118. Zheng Li Company Information Table 119. Zheng Li Business Overview Table 120. Zheng Li Glass Vial for Vaccine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Zheng Li Glass Vial for Vaccine Product Portfolio Table 122. Zheng Li Recent Development Table 123. Gerresheimer Company Information Table 124. Gerresheimer Business Overview Table 125. Gerresheimer Glass Vial for Vaccine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Gerresheimer Glass Vial for Vaccine Product Portfolio Table 127. Gerresheimer Recent Development Table 128. Four Stars Glass Company Information Table 129. Four Stars Glass Business Overview Table 130. Four Stars Glass Glass Vial for Vaccine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Four Stars Glass Glass Vial for Vaccine Product Portfolio Table 132. Four Stars Glass Recent Development Table 133. JOTOP Glass Company Information Table 134. JOTOP Glass Business Overview Table 135. JOTOP Glass Glass Vial for Vaccine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. JOTOP Glass Glass Vial for Vaccine Product Portfolio Table 137. JOTOP Glass Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Glass Vial for Vaccine Distributors List Table 141. Glass Vial for Vaccine Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Glass Vial for Vaccine Product Image Figure 2. Global Glass Vial for Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glass Vial for Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Glass Vial for Vaccine Sales (2021-2032) & (k units) Figure 5. Global Glass Vial for Vaccine Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Glass Vial for Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Molded Glass Vial Image Figure 10. Tubular Glass Vial Image Figure 11. Global Glass Vial for Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Glass Vial for Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Glass Vial for Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Glass Vial for Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Glass Vial for Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Glass Vial for Vaccine Sales Value Share by Type (2021-2032) Figure 17. Preventive Vaccine Image Figure 18. Therapeutic Vaccine Image Figure 19. Global Glass Vial for Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Glass Vial for Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Glass Vial for Vaccine Sales Volume Share by Application (2021-2032) Figure 22. Global Glass Vial for Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Glass Vial for Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Glass Vial for Vaccine Sales Value Share by Application (2021-2032) Figure 25. Global Glass Vial for Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Glass Vial for Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Glass Vial for Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Glass Vial for Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Glass Vial for Vaccine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Glass Vial for Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Glass Vial for Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Glass Vial for Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Glass Vial for Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Glass Vial for Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Glass Vial for Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Glass Vial for Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Glass Vial for Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Glass Vial for Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Glass Vial for Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Glass Vial for Vaccine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Glass Vial for Vaccine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Molded Glass Vial
  • Tubular Glass Vial
Applications
  • Preventive Vaccine
  • Therapeutic Vaccine
Companies covered
  • Schott AG
  • DWK Life Sciences
  • Richland Glass
  • Nipro
  • Pacific Vial Manufacturing
  • Origin Ltd
  • Stevanato Group
  • SGD Pharma
  • Piramal Glass
  • Zheng Chuan
  • Shandong Pharmaceutical Glass
  • Zheng Li
  • Gerresheimer
  • Four Stars Glass
  • JOTOP Glass

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glass Vial for Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Glass Vial for Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Glass Vial for Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Glass Vial for Vaccine Market Dynamics
  1. 2.1 Glass Vial for Vaccine Industry Trends
  2. 2.2 Glass Vial for Vaccine Industry Drivers
  3. 2.3 Glass Vial for Vaccine Industry Opportunities and Challenges
  4. 2.4 Glass Vial for Vaccine Industry Restraints
3 Glass Vial for Vaccine Market by Company
  1. 3.1 Global Glass Vial for Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Glass Vial for Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Glass Vial for Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Glass Vial for Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Glass Vial for Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Glass Vial for Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Glass Vial for Vaccine Company Product Type and Application
  8. 3.8 Global Glass Vial for Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Glass Vial for Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Glass Vial for Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Glass Vial for Vaccine Market by Type
  1. 4.1 Glass Vial for Vaccine Type Introduction
  2. 4.1.1 Molded Glass Vial
  3. 4.1.2 Tubular Glass Vial
  4. 4.2 Global Glass Vial for Vaccine Sales Volume by Type
  5. 4.2.1 Global Glass Vial for Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Glass Vial for Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Glass Vial for Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Glass Vial for Vaccine Sales Value by Type
  9. 4.3.1 Global Glass Vial for Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Glass Vial for Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Glass Vial for Vaccine Sales Value Share by Type (2021-2032)
5 Glass Vial for Vaccine Market by Application
  1. 5.1 Glass Vial for Vaccine Application Introduction
  2. 5.1.1 Preventive Vaccine
  3. 5.1.2 Therapeutic Vaccine
  4. 5.2 Global Glass Vial for Vaccine Sales Volume by Application
  5. 5.2.1 Global Glass Vial for Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Glass Vial for Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Glass Vial for Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Glass Vial for Vaccine Sales Value by Application
  9. 5.3.1 Global Glass Vial for Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Glass Vial for Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Glass Vial for Vaccine Sales Value Share by Application (2021-2032)
6 Glass Vial for Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Glass Vial for Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glass Vial for Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Glass Vial for Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Glass Vial for Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Glass Vial for Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Glass Vial for Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Glass Vial for Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Glass Vial for Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Glass Vial for Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Glass Vial for Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Glass Vial for Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Glass Vial for Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Glass Vial for Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Glass Vial for Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Glass Vial for Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Glass Vial for Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Glass Vial for Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Glass Vial for Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Glass Vial for Vaccine Sales Value Share by Country, 2025 VS 2032
7 Glass Vial for Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Glass Vial for Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Glass Vial for Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Glass Vial for Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Glass Vial for Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Glass Vial for Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Glass Vial for Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Glass Vial for Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Glass Vial for Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Glass Vial for Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Glass Vial for Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Glass Vial for Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Schott AG
  2. 8.1.1 Schott AG Company Information
  3. 8.1.2 Schott AG Business Overview
  4. 8.1.3 Schott AG Glass Vial for Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Schott AG Glass Vial for Vaccine Product Portfolio
  6. 8.1.5 Schott AG Recent Developments
  7. 8.2 DWK Life Sciences
  8. 8.2.1 DWK Life Sciences Company Information
  9. 8.2.2 DWK Life Sciences Business Overview
  10. 8.2.3 DWK Life Sciences Glass Vial for Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 DWK Life Sciences Glass Vial for Vaccine Product Portfolio
  12. 8.2.5 DWK Life Sciences Recent Developments
  13. 8.3 Richland Glass
  14. 8.3.1 Richland Glass Company Information
  15. 8.3.2 Richland Glass Business Overview
  16. 8.3.3 Richland Glass Glass Vial for Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Richland Glass Glass Vial for Vaccine Product Portfolio
  18. 8.3.5 Richland Glass Recent Developments
  19. 8.4 Nipro
  20. 8.4.1 Nipro Company Information
  21. 8.4.2 Nipro Business Overview
  22. 8.4.3 Nipro Glass Vial for Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Nipro Glass Vial for Vaccine Product Portfolio
  24. 8.4.5 Nipro Recent Developments
  25. 8.5 Pacific Vial Manufacturing
  26. 8.5.1 Pacific Vial Manufacturing Company Information
  27. 8.5.2 Pacific Vial Manufacturing Business Overview
  28. 8.5.3 Pacific Vial Manufacturing Glass Vial for Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pacific Vial Manufacturing Glass Vial for Vaccine Product Portfolio
  30. 8.5.5 Pacific Vial Manufacturing Recent Developments
  31. 8.6 Origin Ltd
  32. 8.6.1 Origin Ltd Company Information
  33. 8.6.2 Origin Ltd Business Overview
  34. 8.6.3 Origin Ltd Glass Vial for Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Origin Ltd Glass Vial for Vaccine Product Portfolio
  36. 8.6.5 Origin Ltd Recent Developments
  37. 8.7 Stevanato Group
  38. 8.7.1 Stevanato Group Company Information
  39. 8.7.2 Stevanato Group Business Overview
  40. 8.7.3 Stevanato Group Glass Vial for Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Stevanato Group Glass Vial for Vaccine Product Portfolio
  42. 8.7.5 Stevanato Group Recent Developments
  43. 8.8 SGD Pharma
  44. 8.8.1 SGD Pharma Company Information
  45. 8.8.2 SGD Pharma Business Overview
  46. 8.8.3 SGD Pharma Glass Vial for Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 SGD Pharma Glass Vial for Vaccine Product Portfolio
  48. 8.8.5 SGD Pharma Recent Developments
  49. 8.9 Piramal Glass
  50. 8.9.1 Piramal Glass Company Information
  51. 8.9.2 Piramal Glass Business Overview
  52. 8.9.3 Piramal Glass Glass Vial for Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Piramal Glass Glass Vial for Vaccine Product Portfolio
  54. 8.9.5 Piramal Glass Recent Developments
  55. 8.10 Zheng Chuan
  56. 8.10.1 Zheng Chuan Company Information
  57. 8.10.2 Zheng Chuan Business Overview
  58. 8.10.3 Zheng Chuan Glass Vial for Vaccine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Zheng Chuan Glass Vial for Vaccine Product Portfolio
  60. 8.10.5 Zheng Chuan Recent Developments
  61. 8.11 Shandong Pharmaceutical Glass
  62. 8.11.1 Shandong Pharmaceutical Glass Company Information
  63. 8.11.2 Shandong Pharmaceutical Glass Business Overview
  64. 8.11.3 Shandong Pharmaceutical Glass Glass Vial for Vaccine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Shandong Pharmaceutical Glass Glass Vial for Vaccine Product Portfolio
  66. 8.11.5 Shandong Pharmaceutical Glass Recent Developments
  67. 8.12 Zheng Li
  68. 8.12.1 Zheng Li Company Information
  69. 8.12.2 Zheng Li Business Overview
  70. 8.12.3 Zheng Li Glass Vial for Vaccine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Zheng Li Glass Vial for Vaccine Product Portfolio
  72. 8.12.5 Zheng Li Recent Developments
  73. 8.13 Gerresheimer
  74. 8.13.1 Gerresheimer Company Information
  75. 8.13.2 Gerresheimer Business Overview
  76. 8.13.3 Gerresheimer Glass Vial for Vaccine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Gerresheimer Glass Vial for Vaccine Product Portfolio
  78. 8.13.5 Gerresheimer Recent Developments
  79. 8.14 Four Stars Glass
  80. 8.14.1 Four Stars Glass Company Information
  81. 8.14.2 Four Stars Glass Business Overview
  82. 8.14.3 Four Stars Glass Glass Vial for Vaccine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Four Stars Glass Glass Vial for Vaccine Product Portfolio
  84. 8.14.5 Four Stars Glass Recent Developments
  85. 8.15 JOTOP Glass
  86. 8.15.1 JOTOP Glass Company Information
  87. 8.15.2 JOTOP Glass Business Overview
  88. 8.15.3 JOTOP Glass Glass Vial for Vaccine Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 JOTOP Glass Glass Vial for Vaccine Product Portfolio
  90. 8.15.5 JOTOP Glass Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glass Vial for Vaccine Value Chain Analysis
  2. 9.1.1 Glass Vial for Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glass Vial for Vaccine Sales Mode & Process
  6. 9.2 Glass Vial for Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glass Vial for Vaccine Distributors
  9. 9.2.3 Glass Vial for Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst